{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T20:10:15Z","timestamp":1778530215397,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81171748"],"award-info":[{"award-number":["81171748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31501147"],"award-info":[{"award-number":["31501147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY17H160068"],"award-info":[{"award-number":["LY17H160068"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Experimental Animal Science Project of Zhejiang Province","award":["2018C37123"],"award-info":[{"award-number":["2018C37123"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejphar.2019.01.021","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:06:23Z","timestamp":1548288383000},"page":"96-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Histone deacetylase inhibitor CI-994 inhibits osteoclastogenesis via suppressing NF-\u03baB and the downstream c-Fos\/NFATc1 signaling pathways"],"prefix":"10.1016","volume":"848","author":[{"given":"Di","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiacheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binxiang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.01.021_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ejphar.2019.01.021_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/jn.00238.2016","article-title":"Morphine-induced synaptic plasticity in the VTA is reversed by HDAC inhibition","volume":"116","author":"Authement","year":"2016","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib3","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1365-2362.2012.02717.x","article-title":"The osteoclast, bone remodelling and treatment of metabolic bone disease","volume":"42","author":"Boyce","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.01.021_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.01.021_bib5","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1002\/jcp.22684","article-title":"Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro","volume":"226","author":"Cantley","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib6","article-title":"HDAC inhibitors and RECK modulate endoplasmic reticulum stress in tumor cells","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.01.021_bib7","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/jcp.25389","article-title":"DC-STAMP: a key regulator in osteoclast differentiation","volume":"231","author":"Chiu","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.chembiol.2012.05.010","article-title":"Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis","volume":"19","author":"Chou","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrrheum.2011.23","article-title":"Advances in osteoclast biology: old findings and new insights from mouse models","volume":"7","author":"Edwards","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib10","first-page":"3008","article-title":"Acetyldinaline: a new oral cytostatic drug with impressive differential activity against leukemic cells and normal stem cells--preclinical studies in a relevant rat model for human acute myelocytic leukemia","volume":"53","author":"el-Beltagi","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.01.021_bib11","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2019.01.021_bib12","first-page":"1517","article-title":"CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo","volume":"19","author":"Hubeek","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2019.01.021_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/BJ20110062","article-title":"RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation","volume":"436","author":"Kim","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2019.01.021_bib14","first-page":"19","article-title":"Inhibitory effect of purpurogallin on osteoclast differentiation in vitro through the downregulation of c-Fos and NFATc1","author":"Kim","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.01.021_bib15","first-page":"401","article-title":"Modulation of histone acetylation by [4-(acetylamino)-N-(2-amino-phenyl) benzamide] in HCT-8 colon carcinoma","volume":"2","author":"Kraker","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejphar.2019.01.021_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2016.02.057","article-title":"Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo","volume":"777","author":"Li","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib17","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2165\/11315680-000000000-00000","article-title":"Histone deacetylase inhibitors: current status and overview of recent clinical trials","volume":"69","author":"Ma","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2019.01.021_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib19","doi-asserted-by":"crossref","first-page":"26475","DOI":"10.1074\/jbc.M313973200","article-title":"Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos","volume":"279","author":"Matsuo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.01.021_bib20","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.4049\/jimmunol.175.9.5809","article-title":"Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production","volume":"175","author":"Nakamura","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","article-title":"Osteoimmunology: the conceptual framework unifying the immune and skeletal systems","volume":"97","author":"Okamoto","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2019.01.021_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s00418-018-1636-2","article-title":"Recent advances in osteoclast biology","author":"Ono","year":"2018","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib23","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood-2002-08-2622","article-title":"Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages","volume":"101","author":"Rahman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2019.01.021_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/13543784.16.5.659","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"16","author":"Rasheed","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2019.01.021_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bone.2015.07.018","article-title":"SIRT6 deficiency culminates in low-turnover osteopenia","volume":"81","author":"Sugatani","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.ejphar.2019.01.021_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejphar.2019.01.021_bib27","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/annonc\/mdh438","article-title":"A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine","volume":"15","author":"Undevia","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4161\/epi.25202","article-title":"Class I HDAC imaging using [(3)H]CI-994 autoradiography","volume":"8","author":"Wang","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.ejphar.2019.01.021_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/360741a0","article-title":"Bone and haematopoietic defects in mice lacking c-fos","volume":"360","author":"Wang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.01.021_bib30","article-title":"Bulleyaconitine A prevents Ti particle-induced osteolysis via suppressing NF-kappaB signal pathway during osteoclastogenesis and osteoblastogenesis","author":"Zhang","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2019.01.021_bib31","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jbmr.2771","article-title":"Dihydroartemisinin, an anti-malaria drug, suppresses estrogen deficiency-induced osteoporosis, osteoclast formation, and RANKL-induced signaling pathways","volume":"31","author":"Zhou","year":"2016","journal-title":"J. Bone Miner. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919300548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919300548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T20:38:57Z","timestamp":1565210337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919300548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":31,"alternative-id":["S0014299919300548"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.01.021","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase inhibitor CI-994 inhibits osteoclastogenesis via suppressing NF-\u03baB and the downstream c-Fos\/NFATc1 signaling pathways","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}